(Q33619422)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20585834%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

title

Warfarin dosing algorithm using clinical, demographic and pharmacogenetic data from Chinese patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20585834%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20585834%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Raymond Siu-Ming Wong

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20585834%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Mary Miu-Yee Waye

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20585834%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Kai Chow Choi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20585834%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

author name string

Yawei Mu

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20585834%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Cadmon K Lim

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20585834%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Gregory Cheng

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20585834%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

publication date

1 January 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20585834%20AND%20SRC:MED&resulttype=core&format=json

Journal of Thrombosis and Thrombolysis

6 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20585834%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

volume

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20585834%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20585834%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

page(s)

113-118

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20585834%20AND%20SRC:MED&resulttype=core&format=json

Factors determining the maintenance dose of warfarin in Chinese patients.

6 February 2020

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11239-010-0497-X

Should we be applying warfarin pharmacogenetics to clinical practice? No, not now.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11239-010-0497-X

Cost-effectiveness of using pharmacogenetic information in warfarin dosing for patients with nonvalvular atrial fibrillation

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11239-010-0497-X

Association between CYP2C9 genetic variants and anticoagulation-related outcomes during warfarin therapy

21 January 2018

1 reference

12 December 2020

Is INR between 2.0 and 3.0 the optimal level for Chinese patients on warfarin therapy for moderate-intensity anticoagulation?

1 reference

12 December 2020

Point: use of pharmacogenetics in guiding treatment with warfarin

1 reference

12 December 2020

Validation of VKORC1 and CYP2C9 genotypes on interindividual warfarin maintenance dose: a prospective study in Chinese patients

1 reference

12 December 2020

Dosing algorithm for warfarin using CYP2C9 and VKORC1 genotyping from a multi-ethnic population: comparison with other equations

1 reference

12 December 2020

Interindividual variability in sensitivity to warfarin--Nature or nurture?

1 reference

12 December 2020

Low-dose oral anticoagulation in patients with mechanical heart valve prostheses: final report from the early self-management anticoagulation trial II.

1 reference

12 December 2020

Genetic-based dosing in orthopedic patients beginning warfarin therapy.

1 reference

12 December 2020

Estimation of the warfarin dose with clinical and pharmacogenetic data

1 reference

12 December 2020

A polymorphism in the VKORC1 gene is associated with an interindividual variability in the dose-anticoagulant effect of warfarin.

1 reference

12 December 2020

Association of Vitamin K epoxide reductase complex 1 (VKORC1) variants with warfarin dose in a Hong Kong Chinese patient population

1 reference

12 December 2020

The potential clinical and economic outcomes of pharmacogenetics-oriented management of warfarin therapy - a decision analysis.

1 reference

12 December 2020

Potential clinical and economic outcomes of CYP2C9 and VKORC1 genotype-guided dosing in patients starting warfarin therapy.

1 reference

12 December 2020

Prospective study of warfarin dosage requirements based on CYP2C9 and VKORC1 genotypes

1 reference

12 December 2020

Influence of cytochrome P-450 CYP2C9 polymorphisms on warfarin sensitivity and risk of over-anticoagulation in patients on long-term treatment.

1 reference

12 December 2020

Contribution of age, body weight, and CYP2C9 and VKORC1 genotype to the anticoagulant response to warfarin: proposal for a new dosing regimen in Chinese patients

1 reference

12 December 2020

Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications

1 reference

12 December 2020

Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose

1 reference

12 December 2020

10.1007/S11239-010-0497-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20585834%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference